Title of Collaborative Activity: |
Interagency Agreement with the Food and Drug Administration (FDA) |
Description of Collaborative Activity: |
Interagency Agreement with FDA to determine antibody signatures to respiratory syncytial virus (RSV) infection and vaccination to identify correlates of protection. |
Type of Collaborative Activity: |
Other
|
Year the Collaborative Activity Originated: |
2016 |
NIH Participating Institutes/Centers/Office of the Director: |
NIAID |
HHS Agency Collaborators on this Activity: |
FDA |
